GT BIOPHARMA, INC. (GTBP) Free cash flow 2016–2019
GT BIOPHARMA, INC. (GTBP) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$3.7MFY2019 · since FY2016: -$1.9M → -$3.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2019 | -$3.7M | +65.8% |
| FY2018 | -$10.7M | -97.1% |
| FY2017 | -$5.4M | -181.6% |
| FY2016 | -$1.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice